4D Molecular Therapeutics (FDMT) Non Operating Income (2020 - 2026)
4D Molecular Therapeutics (FDMT) recorded Non Operating Income of $4.09 million in Q2 2026, down 14.8% from $4.8 million a year earlier and down 15.9% from the prior quarter.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Non Operating Income (2020 - 2026) Analysis & Trends
On a TTM basis, 4D Molecular Therapeutics' Non Operating Income came in at $17.94 million as of Jun 30, 2026, down 25.8% year-over-year; for FY2025, it came in at $19.44 million, down 27.9% from FY2024.
- Across earlier years, Non Operating Income came in at $26.97 million in FY2024 (+124.2%), $12.03 million in FY2023 (+374.0%), $2.54 million in FY2022 and $16,000 in FY2021.
- The Q2 2026 figure is the lowest quarterly Non Operating Income since Q3 2023.
- On a year-over-year basis, Non Operating Income has declined for six consecutive quarters, with growth averaging 1.1% over the last eight quarters.
- Peak year-over-year performance for Non Operating Income in the last five years was growth of 641.2% in Q2 2023, against a decline of 40.9% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.86 million (Q1 2026), $4.68 million (Q4 2025) and $4.31 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | - |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | - |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | 4D Molecular Therapeutics | 1.02 Bn | -441.70 Mn | - | 4.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.09 Mn |
| Mar 31, 2026 | 4.86 Mn |
| Dec 31, 2025 | 4.68 Mn |
| Sep 30, 2025 | 4.31 Mn |
| Jun 30, 2025 | 4.80 Mn |
| Mar 31, 2025 | 5.65 Mn |
| Dec 31, 2024 | 6.45 Mn |
| Sep 30, 2024 | 7.29 Mn |
| Jun 30, 2024 | 7.50 Mn |
| Mar 31, 2024 | 5.74 Mn |
| Dec 31, 2023 | 4.37 Mn |
| Sep 30, 2023 | 3.72 Mn |
| Jun 30, 2023 | 2.52 Mn |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | 1.34 Mn |
| Sep 30, 2022 | 804,000.00 |
| Jun 30, 2022 | 340,000.00 |
| Mar 31, 2022 | 54,000.00 |
| Dec 31, 2021 | -319,000.00 |
| Sep 30, 2021 | 422,000.00 |
API Access
4D Molecular Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();